Home › Clear-cell metastatic renal cell carcinoma › Illinois › Waukegan
Clear-cell metastatic renal cell carcinoma clinical trials in Waukegan, IL
4 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in and around Waukegan (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
RecruitingPhase 1
- NEO-811 Chicago Site, Zion · 6 mi away
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
RecruitingPhase 3
- Research Site, Zion · 6 mi away
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- City Of Hope - Chicago, Zion · 6 mi away
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi away
- AMG Libertyville - Oncology, Libertyville · 8 mi away
- Condell Memorial Hospital, Libertyville · 8 mi away
Clear-cell metastatic renal cell carcinoma trials in other cities
- Baldwin Park, CA7 studies
- New York City, NY5 studies
- Dallas, TX5 studies
- Nashville, TN5 studies
- Rochester, MN4 studies
- Cleveland, OH4 studies
- St. Louis, MO4 studies
- Ann Arbor, MI3 studies
- San Francisco, CA3 studies
- Queens, NY3 studies
- Houston, TX3 studies
- San Diego, CA3 studies
Other studies in Waukegan
- Non-Small Cell Lung Cancer16 studies
- Lung Cancer16 studies
- Breast Cancer12 studies
- Ulcerative Colitis7 studies
- Kidney Cancer (Renal Cell Carcinoma)7 studies
- Ovarian Cancer6 studies
- Metastatic Cancer6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Colorectal Cancer6 studies
- Prostate Cancer6 studies
- Melanoma5 studies
- Acute Myeloid Leukemia5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.